Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More
The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More
Learning Mandarin for the Future.Read More
Government Interest in Antimony.Read More
Strategic Joint Venture in Gabon.Read More
Japan Gold's Strong Shareholder Base.Read More
Unearthing Multi-Million Ounce Gold Systems in the Tombstone Gold Belt.Read More
Be the first to know Subscribe to the newsletter: https://tinyurl.com/2p9dzavj 0:00 Intro 0:21 Gold holds momentum as focus ...Read More
This week on Digging for Dollars, Cejay Kim goes solo with Frederick Bell, CEO of Elemental Altus Royalties, right after ...Read More
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) CEO Dr. Seth Lederman talked with Proactive's Stephen Gunnion about the ...Read More
New Era Energy & Digital CEO Will Gray speaks with Proactive about the company's transition into AI-powered infrastructure and ...Read More
Cyprium Metals Executive Chairman Matt Fifield speaks with Proactive after securing final government approval to restart the Nifty ...Read More
Terrain Minerals Executive Director Justin Virgin joins Proactive to discuss the company's latest gold exploration efforts at the ...Read More
Lightning Minerals Managing Director Alex Biggs joins Proactive to share the latest on gold exploration at the Mt Turner Project.Read More
Lightning Minerals Managing Director Alex Biggs joins Proactive to share the latest on gold exploration at the Mt Turner Project.Read More
Novo Resources Executive Co-Chairman Mike Spreadborough updates Proactive on recent high-grade gold and antimony results ...Read More
Race Oncology CEO Dr Daniel Tillett speaks with Proactive about new clinical directions for lead drug RC220, including programs ...Read More
Terrain Minerals Executive Director Justin Virgin joins Proactive to discuss the company's latest gold exploration efforts at the ...Read More
Race Oncology CEO Dr Daniel Tillett speaks with Proactive about new clinical directions for lead drug RC220, including programs ...Read More